» Articles » PMID: 31663115

Tau Deposition in Young Adults with Drug-resistant Focal Epilepsy

Overview
Journal Epilepsia
Specialty Neurology
Date 2019 Oct 31
PMID 31663115
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the presence of tau deposition and pathologic features of chronic traumatic encephalopathy (CTE) in young adult patients treated with focal cortical resections for drug-resistant epilepsy.

Methods: Sixty consecutive patients who had undergone surgical treatment for drug-resistant focal epilepsy between 18 and 45 years of age were identified (2010-2017). Medical records were reviewed to determine clinical factors, including history of head trauma, age at seizure onset, age at surgical resection, seizure type(s) and frequency, imaging findings, and surgical outcome. All formalin-fixed, paraffin-embedded blocks from the surgical specimens from each subject were sectioned and stained with hematoxylin and eosin and antibodies to tau (Thermo Fisher Scientific Clone AT8), and examined blindly for tau pathology, including lesions characteristic of CTE.

Results: The median age at resection was 29.5 years (range = 19-45). A history of head trauma was reported in 19 patients. Although none of the patients had pathological findings characteristic of CTE, 23 patients (38%) demonstrated tau-immunoreactive lesions, including neurites, neurofibrillary pretangles, neurofibrillary tangles, subpial tau, and/or glial tau. In 4 of the 23 patients (7% of the cohort; 17% of those with tau pathology), substantial tau burden was identified. Three of these 4 patients had no significant history of head trauma; 1 patient had multiple sports-related concussions. No specific clinical factors correlated with the presence of tau pathology.

Significance: Tau-immunoreactive lesions were found in 38% of 60 patients who underwent a focal cortical resection for drug-resistant focal epilepsy. Diagnostic features of CTE were not detected in any patient; however, the pathological evaluation for CTE was limited to a surgical specimen. The prominent and excessive tau deposition in 23 patients (38%) is abnormal in this age group and warrants further investigation.

Citing Articles

Activation of the Reelin/GSK-3β/p-Tau Signaling Pathway in the Hippocampus of Patients with Temporal Lobe Epilepsy.

Lin J, Lin X, Fu Y, Li X, Li X, Wang Y Neuropsychiatr Dis Treat. 2025; 21:409-419.

PMID: 40045946 PMC: 11880680. DOI: 10.2147/NDT.S495339.


Enhanced Fyn-tau and NR2B-PSD95 interactions in epileptic foci in experimental models and human epilepsy.

Putra M, Rao N, Gardner C, Liu G, Trommater J, Bunney M Brain Commun. 2024; 6(5):fcae327.

PMID: 39355003 PMC: 11444080. DOI: 10.1093/braincomms/fcae327.


Cellular and pathological functions of tau.

Bravo C, Naguib S, Gan L Nat Rev Mol Cell Biol. 2024; 25(11):845-864.

PMID: 39014245 DOI: 10.1038/s41580-024-00753-9.


Understanding epileptogenesis from molecules to network alteration.

Park K Encephalitis. 2024; 4(3):47-54.

PMID: 38886161 PMC: 11237188. DOI: 10.47936/encephalitis.2024.00038.


Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold.

Ghosh U, Tse E, Yang H, Shi M, Caro C, Wang F Acta Neuropathol Commun. 2024; 12(1):94.

PMID: 38867338 PMC: 11167798. DOI: 10.1186/s40478-024-01806-y.


References
1.
Smith K, Blessing M, Parisi J, Britton J, Mandrekar J, Cascino G . Tau deposition in young adults with drug-resistant focal epilepsy. Epilepsia. 2019; 60(12):2398-2403. PMC: 6973032. DOI: 10.1111/epi.16375. View

2.
Jones A, Britton J, Blessing M, Parisi J, Cascino G . Chronic traumatic encephalopathy in an epilepsy surgery cohort: Clinical and pathologic findings. Neurology. 2018; 90(6):e474-e478. DOI: 10.1212/WNL.0000000000004927. View

3.
Xi Z, Wang X, Shu X, Chen G, Xiao F, Sun J . Is intractable epilepsy a tauopathy?. Med Hypotheses. 2011; 76(6):897-900. DOI: 10.1016/j.mehy.2011.03.003. View

4.
Braak H, Del Tredici K . The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol. 2010; 121(2):171-81. DOI: 10.1007/s00401-010-0789-4. View

5.
Puvenna V, Engeler M, Banjara M, Brennan C, Schreiber P, Dadas A . Is phosphorylated tau unique to chronic traumatic encephalopathy? Phosphorylated tau in epileptic brain and chronic traumatic encephalopathy. Brain Res. 2015; 1630:225-40. PMC: 4853900. DOI: 10.1016/j.brainres.2015.11.007. View